The high frequency of concomitant pathologies in GRN mutation carriers, such as the combination of FTLD with PD or FTLD with AD [55–57], might indicate that loss or partial loss of GRN could advance pathological features of other neurodegenerative diseases in an early stage [58]. Here, GRN is linked to Parkinson disease.